SCHEMBL6058880

SCHEMBL6058880

CCCc1ccc2cc(-c3cc(F)c(-c4cc(F)cc(F)c4)c(F)c3)ccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 5/20 0.38
FGFR1 P11362 1/20 0.38
FGFR2 P21802 1/20 0.38
CYP17A1 P05093 1/20 0.37
CYP21A2 P08686 1/20 0.37
CYP11B1 P15538 1/20 0.37
ESR1 P03372 4/20 0.36
ESR2 Q92731 4/20 0.36
PGR P06401 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KCNH2 Q12809 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35
RARB P10826 2/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
RARA P10276 1/20 0.35
RARG P13631 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3260190 0.92 RARB (0.41) HRH3FGFR1FGFR2CYP17A1CYP21A2
SCHEMBL3162709 0.91 HRH3 (0.43) HRH3FGFR1FGFR2CYP17A1CYP21A2
SCHEMBL6059298 0.91 RARB (0.46) HRH3FGFR1FGFR2RARBRARA
SCHEMBL6059908 0.90 HRH3 (0.39) HRH3ESR1ESR2RARBNPC1
SCHEMBL3153564 0.90 HRH3 (0.39) HRH3ESR1ESR2SLC6A2SLC6A4
SCHEMBL3153225 0.90 CYP17A1 (0.45) HRH3FGFR1FGFR2CYP17A1CYP21A2
SCHEMBL6058943 0.89 RARB (0.48) RARBRARARARGHSD17B10
SCHEMBL6059324 0.89 RARB (0.48) RARBRARARARGHSD17B10
SCHEMBL3160709 0.89 HRH3 (0.38) HRH3ESR1ESR2TAAR1RARB
SCHEMBL3257252 0.88 CYP1A2 (0.43) HRH3FGFR1FGFR2CYP17A1CYP21A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP claimed
US-7145047-B2 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-12-05 US disclosed
EP-1452514-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-09-01 EP disclosed
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-07-24 US disclosed
EP-1273562-A1 Naphthalene derivative and liquid crystal composition comprising the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 EP disclosed
US-6468607-B1 MISCIBILITY, LARGE BIREFRINGENCE INDEX, NO STRONGLY POLAR GROUP IN ITS MOLECULE AND THUS CAN ALSO BE USED FOR ACTIVE MATRIX DRIVING, WIDE TEMPERATURE RANGE AND REQUIRES A HIGH SPEED RESPONSE AND A LOW VOLTAGE DRIVING DAINIPPON INK AND CHEMICALS, INC. (JP) 2002-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030136944-A1 Naphthalene derivative and liquid crystal composition comprising the same NLK, NOTCH1, NOTCH4 HRH3 3421/4885FGFR1 2660/4885FGFR2 1777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.